Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...

Education

Pharmaceutical

Alimera Sciences

Rick Eiswirth

Kapil Kumar

Tom Sinnamon

Bryce Werner

Ben Flagler

Sergei Donskihh

Deirdre O Reilly

Catherine Griffiths

Diane Reeves

Liz Michael

Kotaro Sai

David Gregory

Bill Garner

Trey Kincaid

Steve Morris

Riz Siddiqi

Mike Padilla

Larry Karner

Brittany Underhill

Benjamin Simon

Laura Cegala Sphr, Gphr

Christopher Visick

Steve Gill

David Dyer

Russell Skibsted

David Holland

The Leadership Team at Alimera Sciences is responsible for strategic decision-making and guiding the company's vision in ophthalmic pharmaceutical development. Comprising key executives such as the CEO, CMO, and Chief Retina Specialist, the team collaborates to oversee product commercialization, corporate communications, and operational efficiency, ensuring the successful delivery of innovative therapies like ILUVIEN to the market.

Leadership Team

Sales and Marketing

Medical Affairs

Leadership Team

About

Team members

Other teams at Alimera Sciences

Sales and Marketing

Medical Affairs